Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	50.19	55.14	97.47	79.51	164.89
Short-Term Investments	285.88	202.96	326.68	446.73	285.61
Cash & Short-Term Investments	336.08	258.11	424.15	526.24	450.5
Cash Growth	30.21%	-39.15%	-19.40%	16.81%	50.48%
Accounts Receivable	84.76	69.02	51.13	52.75	139.15
Other Receivables	6.85	8.01	6.31	22.36	4.15
Receivables	91.61	77.03	57.45	75.11	143.3
Prepaid Expenses	5.1	6.63	7.74	6.81	4.24
Other Current Assets	117.7	11.81	18.5	19.71	13.92
Total Current Assets	550.49	353.57	507.85	627.87	611.96
Property, Plant & Equipment	117.85	111.72	95.62	98.92	71.16
Long-Term Investments	384.27	595.28	444.01	339.03	507.01
Goodwill	25.08	22.06	22.06	143.03	50.9
Other Intangible Assets	133.28	134.98	143.05	150.64	35.91
Long-Term Deferred Tax Assets	-	-	-	3.5	0.76
Other Long-Term Assets	2.56	2.37	22.75	23.05	1.02
Total Assets	1,214	1,220	1,235	1,386	1,279
Accounts Payable	18.65	18.36	15.36	23.09	20.49
Accrued Expenses	32.24	22.44	26.24	17.91	15.52
Short-Term Debt	0.48	0.41	-	15	21.28
Current Portion of Long-Term Debt	-	-	1.18	5.64	-
Current Portion of Leases	1.82	1.84	4.5	7.08	2.17
Current Income Taxes Payable	-	-	-	-	0.79
Current Unearned Revenue	3.64	2.23	2.87	3.2	14.57
Other Current Liabilities	28.15	27.61	22.86	16.2	30.49
Total Current Liabilities	84.97	72.9	73.02	88.11	105.31
Long-Term Debt	1.96	2.49	2.96	-	-
Long-Term Leases	3.78	4.48	7.91	10.61	6.74
Long-Term Deferred Tax Liabilities	6.94	6.37	7.96	-	-
Other Long-Term Liabilities	9.17	4.56	10.19	17.46	0.79
Total Liabilities	106.81	90.81	102.04	116.18	112.84
Common Stock	0	0	0	0	0
Additional Paid-In Capital	574.52	543.13	501.72	486.59	501.91
Retained Earnings	529.95	590.47	633.18	801	657.6
Comprehensive Income & Other	7.51	-0.37	1.21	-20.9	-0.76
Total Common Equity	1,112	1,133	1,136	1,267	1,159
Minority Interest	-5.27	-4.07	-2.82	3.19	7.13
Shareholders' Equity	1,107	1,129	1,133	1,270	1,166
Total Liabilities & Equity	1,214	1,220	1,235	1,386	1,279
Total Debt	8.04	9.23	16.56	38.33	30.2
Net Cash (Debt)	697.31	819.23	831.17	814.56	905.35
Net Cash Growth	-14.88%	-1.44%	2.04%	-10.03%	117.48%
Net Cash Per Share	22.66	27.10	27.91	26.31	29.23
Filing Date Shares Outstanding	31.23	30.83	29.78	29.52	30.25
Total Common Shares Outstanding	31.08	30.84	29.65	29.44	30.16
Working Capital	465.52	280.67	434.83	539.77	506.65
Book Value Per Share	35.78	36.74	38.31	43.03	38.42
Tangible Book Value	953.63	976.2	970.99	973.02	1,072
Tangible Book Value Per Share	30.68	31.65	32.75	33.05	35.54
Land	17.35	17.35	8.8	7.5	7.5
Buildings	54.89	49.61	17.53	12.6	10.67
Machinery	80.71	76.07	73.65	71.97	51.22
Leasehold Improvements	4.47	3.32	11.22	11.8	4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.